Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-D CRT vs IMRT in Post-Prostatectomy Prostate Cancer
NCT02678520Phase 2Withdrawn
- Sponsor
- University of Kansas Medical Center
- Start
- Dec 2015
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by University of Kansas Medical Center. Primary endpoints: Acute rectal, bladder and other toxicity rates - Participants 1-10, Acute rectal, bladder and other toxicity rates - All participants at 2 years and 3 more. Planned start Dec 2015; status: withdrawn.
Beyond the preview
Go deeper on NCT02678520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678520.